Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shannon D Chilewski

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bioanalysis|June 12, 2025
The case for calibration-free concentration analysisShannon D Chilewski
Bioanalysis|June 6, 2015
Choosing the right bioanalytical assay platform(s) to support the PK assessment of protein biotherapeutic programsShannon D Chilewski, Hao Jiang
The AAPS Journal|April 26, 2018
Generic Anti-PEG Antibody Assay on ProterixBio's (Formerly BioScale) ViBE Platform Shows Poor ReproducibilityShannon D Chilewski, Julie Shields, Johanna R Mora, et al.
Bioanalysis|May 17, 2014
Addressing matrix effects in ligand-binding assays through the use of new reagents and technologyShannon D Chilewski, Johanna R Mora, Carol Gleason, et al.
The AAPS Journal|September 24, 2014
Evaluation of acoustic membrane microparticle (AMMP) technology for a sensitive ligand binding assay to support pharmacokinetic determinations of a biotherapeuticShannon D Chilewski, W Matthew Dickerson, Johanna R Mora, et al.
Bioanalysis|April 29, 2020
Strategies for method comparison when changes in the immunogenicity method are needed within a clinical programJohanna R Mora, Joleen T White, Shannon D Chilewski, et al.
Journal of Immunoassay & Immunochemistry|July 7, 2011
Validation of preclinical pharmacokinetic and immunogenicity assays for an anti-PCSK9 antibodyShannon D Chilewski, Thy Follmer, Frances Ansbro, et al.
Analytical Chemistry|April 11, 2024
Overcoming Lot-to-Lot Variability in Protein Activity Using Epitope-Specific Calibration-Free Concentration AnalysisIan B Harvey, Shannon D Chilewski, Devyani Bhosale, et al.
Cell Cycle (Georgetown, Tex.)|January 15, 2020
Development of CAPER peptides for the treatment of triple negative breast cancerShannon D Chilewski, Devyani Bhosale, Sundee Dees, et al.
The AAPS Journal|July 4, 2015
Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle TechnologyHuijin Dong, Johanna R Mora, Catherine Brockus, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioanalysis|June 12, 2025
The case for calibration-free concentration analysisShannon D Chilewski
Bioanalysis|June 6, 2015
Choosing the right bioanalytical assay platform(s) to support the PK assessment of protein biotherapeutic programsShannon D Chilewski, Hao Jiang
The AAPS Journal|April 26, 2018
Generic Anti-PEG Antibody Assay on ProterixBio's (Formerly BioScale) ViBE Platform Shows Poor ReproducibilityShannon D Chilewski, Julie Shields, Johanna R Mora, et al.
Bioanalysis|May 17, 2014
Addressing matrix effects in ligand-binding assays through the use of new reagents and technologyShannon D Chilewski, Johanna R Mora, Carol Gleason, et al.
The AAPS Journal|September 24, 2014
Evaluation of acoustic membrane microparticle (AMMP) technology for a sensitive ligand binding assay to support pharmacokinetic determinations of a biotherapeuticShannon D Chilewski, W Matthew Dickerson, Johanna R Mora, et al.
Bioanalysis|April 29, 2020
Strategies for method comparison when changes in the immunogenicity method are needed within a clinical programJohanna R Mora, Joleen T White, Shannon D Chilewski, et al.
Journal of Immunoassay & Immunochemistry|July 7, 2011
Validation of preclinical pharmacokinetic and immunogenicity assays for an anti-PCSK9 antibodyShannon D Chilewski, Thy Follmer, Frances Ansbro, et al.
Analytical Chemistry|April 11, 2024
Overcoming Lot-to-Lot Variability in Protein Activity Using Epitope-Specific Calibration-Free Concentration AnalysisIan B Harvey, Shannon D Chilewski, Devyani Bhosale, et al.
Cell Cycle (Georgetown, Tex.)|January 15, 2020
Development of CAPER peptides for the treatment of triple negative breast cancerShannon D Chilewski, Devyani Bhosale, Sundee Dees, et al.
The AAPS Journal|July 4, 2015
Development of a Generic Anti-PEG Antibody Assay Using BioScale's Acoustic Membrane MicroParticle TechnologyHuijin Dong, Johanna R Mora, Catherine Brockus, et al.
Pageof 2